Document Detail


Are treatment effects of ACEI and ARB in post-MI patients homogeneous?
MedLine Citation:
PMID:  19390158     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Authors:
Tetsuji Miura; Satoshi Yuda
Related Documents :
17917438 - Kuwait acute coronary syndromes registry: baseline characteristics, management practice...
20678388 - Reperfusion therapy for acute vertebrobasilar occlusion.
14678918 - Triage of patients with acute chest pain and possible cardiac ischemia: the elusive sea...
19947308 - Comparing the psychological stress between non-smoking patients and smoking patients wh...
10215978 - Predialysis education helps patients choose dialysis modality and increases disease-spe...
23271918 - Value of routine chest radiography in the diagnostic work-up of ill returned travelers.
Publication Detail:
Type:  Comment; Editorial    
Journal Detail:
Title:  Circulation journal : official journal of the Japanese Circulation Society     Volume:  73     ISSN:  1346-9843     ISO Abbreviation:  Circ. J.     Publication Date:  2009 May 
Date Detail:
Created Date:  2009-04-24     Completed Date:  2009-08-03     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101137683     Medline TA:  Circ J     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  820-1     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angiotensin II Type 1 Receptor Blockers / adverse effects,  therapeutic use*
Angiotensin-Converting Enzyme Inhibitors / adverse effects,  therapeutic use*
Asian Continental Ancestry Group
Disease Progression
Humans
Myocardial Infarction / complications,  drug therapy*,  ethnology
Stroke Volume / drug effects
Tetrazoles / adverse effects,  therapeutic use*
Time Factors
Treatment Outcome
Valine / adverse effects,  analogs & derivatives*,  therapeutic use
Ventricular Dysfunction, Left / ethnology,  etiology,  prevention & control*
Ventricular Remodeling / drug effects
Chemical
Reg. No./Substance:
0/Angiotensin II Type 1 Receptor Blockers; 0/Angiotensin-Converting Enzyme Inhibitors; 0/Tetrazoles; 137862-53-4/valsartan; 7004-03-7/Valine
Comments/Corrections
Comment On:
Circ J. 2009 May;73(5):918-24   [PMID:  19346662 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  ALINE: a WYSIWYG protein-sequence alignment editor for publication-quality alignments.
Next Document:  Oral carcinogenicity and toxicity of 2-amino-4-chlorophenol in rats.